August 2022 – Congratulations to Alexis Kiyanda for successfully presenting her BU STaRS research project “Differential protein expression of lamin A/C and cytokeratin-19 in black and white patients with prostate cancer“.
July 2022 – Thanks to Marija Stojanova for all her contributions to the lab and we wish her well in her new position!
May 2022 – Congratulations to Elizabeth Nelson and Griffin Salus for graduating from BU!
May 2022 – Congratulations to Griffin Salus for successfully defending his Master’s thesis titled “Lamin A/C Downregulation Alters Prostate Cancer Cellular Phenotypes” from the Program of Biochemistry and Molecular Biology at BU.
– Dr. Heaphy
presented “Clinicopathological and molecular characteristics of ALT-positive cancers
” virtually at the Telomeres and Cancer Biology International Conference
hosted by the German Cancer Research Center (DFKZ) and Heidelberg University Hospital.
– Congratulations to Elizabeth Nelson
and Griffin Salus for presenting posters (in person) at Experimental Biology in Philadelphia, PA! Elizabeth presented “Investigating the Molecular and Phenotypic Differences in Pancreatic Neuroendocrine Tumor (PanNET) Cells with Functional Loss of Either ATRX or DAXX” and Griffin presented “Lamin A/C Downregulation Alters Prostate Cancer Cellular Phenotypes“.
– Dr. Heaphy
has joined the Editorial Board of Endocrine-Related Cancer
, the official flagship journal of the Society for Endocrinology.
– Latest collaborative work in Ophthalmology with investigators at Wills Eye Hospital and Johns Hopkins Hospital
confirms frequent mutations in ATRX
, and BRAF
in conjunctival melanoma. Interestingly, loss of ATRX and ALT activation may represent early molecular alterations in conjunctival melanoma development.
January 2022 – Welcome to Dr. Joakin Mori – he joins the Heaphy Lab as a postdoctoral fellow. Dr. Mori recently completed his doctoral work in prostate cancer research at Tuskegee University.
– Check out our latest collaborative review article highlighting the “Clinical implications of cell-of-origin epigenetic characterizes in non-functional pancreatic neuroendocrine tumors
” in the Journal of Pathology
– Congratulations to Marija Stojanova
for successfully presenting her poster at the BU Department of Medicine Evans Day
that highlighted her research project “Cellular characterization of prostate cancer cells with functional loss of ATRX or DAXX
– Molecular Minute article in Cancer Cytopathology written with Dr. Christopher VandenBussche (Johns Hopkins Hospital) in which we evaluate
the current prognostic biomarkers in pancreatic neuroendocrine tumors, including ATRX/DAXX loss and ALT.
– Our latest collaborative work with Dr. Fausto Rodriguez and colleagues at Johns Hopkins Hospital was published in Modern Pathology. We demonstrate that, in addition to ATRX loss, ALT-positive tumors harboring SMARCAL1 alterations are prevalent in giant cell GBM.
– Along with Dr. Josh Campbell
and Dr. Rachel Flynn
, the Heaphy Lab is honored to receive a BU CTSI Integrated Pilot Grant
! The overall goal of this pilot project is to identify coding and non-coding genomic alterations in the racially and socioeconomically diverse patient population surgically treated for prostate cancer at Boston Medical Cancer.
January 2021 – We are excited to have two undergraduate students, Elizabeth Nelson and Griffin Salus, join our lab. Welcome Elizabeth and Griffin!
– We are thankful to be selected for a Shipley Prostate Cancer Pilot Grant
from the Boston University School of Medicine! We are excited to evaluate telomere length alterations and nuclear lamin dysfunction in the diverse patient population at Boston Medical Center.
January 2020 – We are really excited that Marija Stojanova has decided to join our lab as a Research Assistant/Lab Manager. She will be instrumental in getting the Heaphy lab off the ground at BU/BMC. Welcome, Marija!
November 2019 – Coming this week: the Heaphy Lab will be at the Boston University School of Medicine/Boston Medical Center!
October 2019 – Today is definitely bittersweet – Johns Hopkins has been an outstanding place….we will miss our colleagues and friends, but look forward to future collaborations!